Ocaliva approved for rare liver disease

Tuesday, May 31, 2016 - 13:31 in Health & Medicine

HealthDay News Ocaliva has been approved by the U.S. Food and Drug Administration to treat a rare chronic liver disease called primary biliary cholangitis.

Read the whole article on UPI

More from UPI

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net